Nancy Reau to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Nancy Reau has written about Carcinoma, Hepatocellular.
Connection Strength
1.215
-
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. Hepatology. 2022 12; 76(6):1766-1777.
Score: 0.829
-
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatol Commun. 2022 11; 6(11):3247-3259.
Score: 0.213
-
Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. Dig Liver Dis. 2020 01; 52(1):98-101.
Score: 0.173